Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Full Schedule
Home
Full Schedule
All Days
On Demand
Fri, Oct 18
Sat, Oct 19
Sun, Oct 20
Mon, Oct 21
Tue, Oct 22
Wed, Oct 23
Thu, Oct 24
Full Schedule
Type here to filter the list
Wednesday, October 23, 2024
7:30 AM – 8:30 AM
MT
Women in PharmSci Breakfast
7:30 AM – 8:30 AM
MT
Women in PharmSci Breakfast
Location: Salt Lake AB, Hyatt Regency Salt Lake City
Career Development
Sponsored By
7:30 AM – 3:30 PM
MT
Speaker Ready Room
7:30 AM – 3:30 PM
MT
Speaker Ready Room
Location: 250 DE
8:00 AM – 2:30 PM
MT
Registration Hours
8:00 AM – 2:30 PM
MT
Registration Hours
Location: South Registration
8:00 AM – 7:00 PM
MT
Coat Check
8:00 AM – 7:00 PM
MT
Coat Check
Location: East Registration, Salt Palace Convention Center
8:30 AM – 12:30 PM
MT
Free Professional Headshots
8:30 AM – 12:30 PM
MT
Free Professional Headshots
Location: Careers 360, Exhibit Hall
Career Development
Sponsored By
8:30 AM – 12:30 PM
MT
LinkedIn Profile Critiques & Resume Reviews
8:30 AM – 12:30 PM
MT
LinkedIn Profile Critiques & Resume Reviews
Location: Careers 360, Exhibit Hall
Career Development
8:30 AM – 12:30 PM
MT
Mock Interviews
8:30 AM – 12:30 PM
MT
Mock Interviews
Location: Careers 360, Exhibit Hall
Career Development
8:30 AM – 1:30 PM
MT
Solution Center Hours & Poster Presentations
8:30 AM – 1:30 PM
MT
Solution Center Hours & Poster Presentations
Location: Exhibit Halls 1 and A-D
9:00 AM – 10:00 AM
MT
Symbiotic Approaches for Rapid and Cost-Effective Manufacturing of Multiparticulate Formulations
Partner Presentation Speaker:
Nitin K. Swarnakar, PhD (he/him/his)
– BASF Corp
Partner Presentation Speaker:
Ramesh Muttavarapu, MS
– Thermo Fisher Scientific
Formulation and Delivery
9:00 AM – 10:00 AM
MT
Symbiotic Approaches for Rapid and Cost-Effective Manufacturing of Multiparticulate Formulations
Location: 360 Stage #1, Exhibit Hall
Partner Presentation Speaker:
Nitin K. Swarnakar, PhD (he/him/his)
– BASF Corp
Partner Presentation Speaker:
Ramesh Muttavarapu, MS
– Thermo Fisher Scientific
Formulation and Delivery
Sponsored By
9:00 AM – 10:30 AM
MT
Symposium: Advancing Vaccine Development: Utilizing the Power of Model-Based Approaches 1
Moderator:
Philip J. Kuehl, PhD
– Lovelace Biomedical
Preclinical, Clinical and Translational Sciences
9:00 AM – 10:30 AM
MT
Symposium: Advancing Vaccine Development: Utilizing the Power of Model-Based Approaches 1
Location: 251 ABC
Moderator:
Philip J. Kuehl, PhD
– Lovelace Biomedical
Preclinical, Clinical and Translational Sciences
9:00 AM – 9:30 AM
MT
Model-Informed Vaccine Development Opportunities
Location: 251 ABC
Speaker:
Rohit Rao, PhD
– Pfizer
Preclinical, Clinical and Translational Sciences
9:30 AM – 10:00 AM
MT
Pharmacometrics Symbiotically Infects Vaccinology: MIDD for Increasing PoS and Reducing Resource Use
Location: 251 ABC
Speaker:
Jeffrey R. Sachs, SC.B., Sc.M., PhD, ACDRS (he/him/his)
– Quantitative Pharmacology and Pharmacometrics, Research Labs of Merck and Co., Inc.
Preclinical, Clinical and Translational Sciences
10:00 AM – 10:30 AM
MT
Modeling Adaptation of the Virulence of a Pathogen to Escape Vaccine-Induced Immunity
Location: 251 ABC
Speaker:
Veronika Bernhauerová, PhD
– Charles University
Preclinical, Clinical and Translational Sciences
9:00 AM – 10:30 AM
MT
Symposium: Advancing Vaccine Development: Utilizing the Power of Model-Based Approaches 2
Moderator:
Christopher Rowbottom, BS
– Moderna TX
Preclinical, Clinical and Translational Sciences
9:00 AM – 10:30 AM
MT
Symposium: Advancing Vaccine Development: Utilizing the Power of Model-Based Approaches 2
Location: 251 DE
Moderator:
Christopher Rowbottom, BS
– Moderna TX
Preclinical, Clinical and Translational Sciences
9:00 AM – 9:30 AM
MT
A Dual Prophylactic/therapeutic Vaccine Against Pseudomonas Aeruginosa
Location: 251 DE
Speaker:
Wendy Picking, PhD (she/her/hers)
– University of Missouri-Columbia
Preclinical, Clinical and Translational Sciences
9:30 AM – 10:00 AM
MT
Patient Focused Vaccine Drug Product Development: Formulation, Process and Manufacturing Approaches
Location: 251 DE
Speaker:
Li Li, PhD (she/her/hers)
– Pfizer
Preclinical, Clinical and Translational Sciences
10:00 AM – 10:30 AM
MT
Multi-Strain Sars-CoV-2 Neutralization Assay Qualification'
Location: 251 DE
Speaker:
Min Zhao, PhD (she/her/hers)
– Moderna Therapeutics
Preclinical, Clinical and Translational Sciences
9:00 AM – 11:00 AM
MT
Symposium: Advanced Drug Delivery Technologies for Targeted Therapeutics
Moderator:
Alejandro J. Paredes, Ph.D.
– Queen's University Belfast
Formulation and Delivery
9:00 AM – 11:00 AM
MT
Symposium: Advanced Drug Delivery Technologies for Targeted Therapeutics
Location: 155 C
Moderator:
Alejandro J. Paredes, Ph.D.
– Queen's University Belfast
Formulation and Delivery
9:00 AM – 9:30 AM
MT
Engineering Nano-Bio Interface to Precisely Control Lipid Nanoparticle Tissue Tropism
Location: 155 C
Speaker:
Fan Zhang, PhD (he/him/his)
– University of Florida
Formulation and Delivery
9:30 AM – 10:00 AM
MT
Unraveling Nanomedicine Complexities: Anti-Inflammatory Immunomodulation and Biomolecular Corona Immunogenicity Dissected
Location: 155 C
Speaker:
Ryan M. Pearson, PhD
– University of Maryland Baltimore
Formulation and Delivery
10:00 AM – 10:30 AM
MT
Polymeric Microneedle Systems for Transdermal and Intradermal Drug Delivery
Location: 155 C
Speaker:
Ryan Donnelly, Ph.D. (he/him/his)
– Queen's University Belfast
Formulation and Delivery
10:30 AM – 11:00 AM
MT
Preclinical and Clinical Development of a Microneedle Patch for Measles-Rubella Vaccination
Location: 155 C
Speaker:
Sebastien Henry, MS MBA
– Micron Biomedical, Inc
Formulation and Delivery
9:00 AM – 11:00 AM
MT
Symposium: Challenges and Lessons Learned in Commercializing (Manufacturing and Product Quality Analysis) Novel Modalities 1
Moderator:
Thilak Mudalige, PhD (he/him/his)
– US Food and Drug Administration
Manufacturing & Analytical Characterization
9:00 AM – 11:00 AM
MT
Symposium: Challenges and Lessons Learned in Commercializing (Manufacturing and Product Quality Analysis) Novel Modalities 1
Location: 155 E
Moderator:
Thilak Mudalige, PhD (he/him/his)
– US Food and Drug Administration
Manufacturing & Analytical Characterization
9:00 AM – 9:30 AM
MT
Advanced Applications of Infrared and Raman Spectroscopy in Pharmaceutical Characterization
Location: 155 E
Speaker:
Huzeyfe Yilmaz, PhD
– US Food and Drug Administration
Manufacturing & Analytical Characterization
9:30 AM – 10:00 AM
MT
Advances in PAT for Steriles Drug Product Manufacturing
Location: 155 E
Speaker:
Parind M. Desai, PhD
– GSK
Manufacturing & Analytical Characterization
10:00 AM – 10:30 AM
MT
Leveraging Synchrotron Tomography Analysis to Engineer Better Spray Dried Particles
Location: 155 E
Speaker:
Tatiana Marcozzi, MA
– Johnson and Johnson Innovative Medicine
Manufacturing & Analytical Characterization
10:30 AM – 11:00 AM
MT
A Game-Changing Quality Control Strategy: The Multi-Attribute Method
Location: 155 E
Speaker:
Kevin Carrick, PhD (he/him/his)
– United States Pharmacopeia
Manufacturing & Analytical Characterization
9:00 AM – 11:00 AM
MT
Symposium: Challenges and Lessons Learned in Commercializing (Manufacturing and Product Quality Analysis) Novel Modalities 2
Moderator:
Anuji Abraham, PhD
– Bristol-Myers Squibb Company
Manufacturing & Analytical Characterization
9:00 AM – 11:00 AM
MT
Symposium: Challenges and Lessons Learned in Commercializing (Manufacturing and Product Quality Analysis) Novel Modalities 2
Location: 155 F
Moderator:
Anuji Abraham, PhD
– Bristol-Myers Squibb Company
Manufacturing & Analytical Characterization
9:00 AM – 9:30 AM
MT
Data Control and Data Security Management in Pharmaceutical Quality Assurance
Location: 155 F
Speaker:
Kim Huynh-Ba, M.S., PMP, FAAPS
– Pharmalytik
Manufacturing & Analytical Characterization
9:30 AM – 10:00 AM
MT
Apply Various Model Systems for Comprehensive Risk Assessment of Aggregates
Location: 155 F
Speaker:
Cathie (Dong) XIANG, Master (she/her/hers)
– Amgen Inc
Manufacturing & Analytical Characterization
10:00 AM – 10:30 AM
MT
Distributed Manufacturing: Personalization of 3DPrinted Intravaginal-Rings by Droplet Deposition Modeling
Location: 155 F
Speaker:
Ahmed S. Zidan, PhD (he/him/his)
– US Food and Drug Administration
Manufacturing & Analytical Characterization
10:30 AM – 11:00 AM
MT
Personalized Transdermal Patches: Adhesion Testing Using Innovative Skin Mimetic Substrates
Location: 155 F
Speaker:
Mandip Singh sachdeva, PhD, FAAPS
– Florida A & M University
Manufacturing & Analytical Characterization
9:00 AM – 11:00 AM
MT
Symposium: Innovative Approaches for Inhaled Delivery
Moderator:
Nitesh K. Kunda, PhD
– St. John's University
Formulation and Delivery
9:00 AM – 11:00 AM
MT
Symposium: Innovative Approaches for Inhaled Delivery
Location: 155 B
Moderator:
Nitesh K. Kunda, PhD
– St. John's University
Formulation and Delivery
9:00 AM – 9:30 AM
MT
Drug Delivery Strategies and Challenges for Pulmonary Nucleic Acid Delivery
Location: 155 B
Speaker:
Jenny KW Lam, MPharm, PhD (she/her/hers)
– University College London
Formulation and Delivery
9:30 AM – 10:00 AM
MT
Inhaled Vaccines: Advancing Respiratory Infection Prevention and Overcoming Current Limitations
Location: 155 B
Speaker:
Pavan Muttil, PhD
– College of Pharmacy, University of New Mexico
Formulation and Delivery
10:00 AM – 10:30 AM
MT
Spray-Dried Phospholipid Porous Particles for Inhalation - Product Quality Studies
Location: 155 B
Speaker:
Yang Yang, PhD (she/her/hers)
– US Food and Drug Administration
Formulation and Delivery
10:30 AM – 11:00 AM
MT
Surfactant Dry Powder Formulations for Premature Babies
Location: 155 B
Speaker:
Michael Hindle, PhD
– Virginia Commonwealth University
Formulation and Delivery
9:00 AM – 11:00 AM
MT
Symposium: Innovative Methodologies for Advancing Therapeutics from Bench to Bedside
Moderator:
Rosalinde Masereeuw, PhD (she/her/hers)
– Utrecht Institute for Pharmaceutical Sciences
Discovery and Basic Research
9:00 AM – 11:00 AM
MT
Symposium: Innovative Methodologies for Advancing Therapeutics from Bench to Bedside
Location: 251 F
Moderator:
Rosalinde Masereeuw, PhD (she/her/hers)
– Utrecht Institute for Pharmaceutical Sciences
Discovery and Basic Research
9:00 AM – 9:30 AM
MT
Roadmap to Designing and Selecting LNPs for mRNA Drug Delivery
Location: 251 F
Speaker:
Annette Bak, Ph.D., M.B.A., FAAPS (she/her/hers)
– AstraZeneca
Discovery and Basic Research
9:30 AM – 10:00 AM
MT
Imaging to Predict Nanomedicine Treatment Efficacy in Solid Tumors: The Growing Role of Ultrasound
Location: 251 F
Speaker:
Agata Exner, PhD (she/her/hers)
– Case Western Reserve University
Discovery and Basic Research
10:00 AM – 10:30 AM
MT
Virtual Bioequivalence Frameworks and Workflows
Location: 251 F
Speaker:
Frederic Y. Bois, PhD
– Certara UK Ltd
Discovery and Basic Research
10:30 AM – 11:00 AM
MT
Radionuclide Theranostics of Brain Tumors: The Potential for Personalized Medicine Through Molecular Imaging
Location: 251 F
Speaker:
Michael Veronesi, MD, PhD (he/him/his)
– University of Wisconsin SMPH
Discovery and Basic Research
9:00 AM – 11:00 AM
MT
Symposium: Regulatory Implications for Bioanalysis 1
Moderator:
Manish Kumar, PhD (he/him/his)
– Daiichi Sankyo
Bioanalytics
9:00 AM – 11:00 AM
MT
Symposium: Regulatory Implications for Bioanalysis 1
Location: 150 DEFG
Moderator:
Manish Kumar, PhD (he/him/his)
– Daiichi Sankyo
Bioanalytics
9:00 AM – 9:30 AM
MT
Comparison of Different Platforms for Evaluating Cellular and Humoral Immunogenicity
Location: 150 DEFG
Speaker:
Yanshan Dai, PhD (he/him/his)
– Bristol-Myers Squibb
Bioanalytics
9:30 AM – 10:00 AM
MT
Challenging Current Immunogenicity Assessment: Clinical Case Studies for 1-Tiered Approach
Location: 150 DEFG
Speaker:
Ching-Ha (Vicky) Lai, PhD (she/her/hers)
– Regeneron Pharmaceuticals Inc
Bioanalytics
10:00 AM – 10:30 AM
MT
Collaborative Training Initiatives for Strengthening Regulatory and Laboratory Systems
Location: 150 DEFG
Speaker:
Chaitanya K. Koduri, MTech (he/him/his)
– US Pharmacopeia
Bioanalytics
10:30 AM – 11:00 AM
MT
The Road to IVD Companion Diagnostics – Pathways to IDE
Location: 150 DEFG
Speaker:
Luke Armstrong, PhD (he/him/his)
– BioAgilytix
Bioanalytics
9:00 AM – 11:00 AM
MT
Symposium: Regulatory Implications for Bioanalysis 2
Moderator:
Darshana Jani, Ph.D.
– Moderna Therapeutics
Bioanalytics
9:00 AM – 11:00 AM
MT
Symposium: Regulatory Implications for Bioanalysis 2
Location: 151 ABCG
Moderator:
Darshana Jani, Ph.D.
– Moderna Therapeutics
Bioanalytics
9:00 AM – 9:30 AM
MT
Unraveling CGTP Compliance: Part 1- Biomarker Assay Selection and Pitfalls
Location: 151 ABCG
Speaker:
Stephanie A. Pasas-Farmer, PhD (she/her/hers)
– BioData Solutions LLC
Bioanalytics
9:30 AM – 10:00 AM
MT
Unraveling CGTP Compliance: Part 2- Comparative Study Fabry Associated Biomarkers
Location: 151 ABCG
Speaker:
Josephine Y. Fang, PhD (she/her/hers)
– Takeda
Bioanalytics
10:00 AM – 10:30 AM
MT
NAb Assays for ADC: Killing or Not Killing?
Location: 151 ABCG
Speaker:
Weifeng Xu, Ph.D.
– Merck & Co., Inc.
Bioanalytics
10:30 AM – 11:00 AM
MT
How Would the European In Vitro Diagnostic Regulation 2017/746 (EU IVDR) Impact Regulated Bioanalysis?
Location: 151 ABCG
Speaker:
Don (Zhandong) Zhong, PhD (he/him/his)
– Denali Therapeutics
Bioanalytics
9:30 AM – 10:00 AM
MT
Coffee Break in the Solution Center
9:30 AM – 10:00 AM
MT
Coffee Break in the Solution Center
Location: Exhibit Halls 1 and A-D
9:30 AM – 10:25 AM
MT
Special Poster Collection
9:30 AM – 10:25 AM
MT
Special Poster Collection
Location: Poster Forum #8, Exhibit Hall
Poster Collection Host:
Robert O. Williams, III, PhD (he/him/his)
– The University of Texas at Austin
9:30 AM – 10:30 AM
MT
Mitigating Nitrosamine Risks: An In-Silico Approach to Identifying NDSRIs and Evaluating API-Excipient Interactions
Partner Presentation Speaker:
Rainer Dobrawa, PhD (he/him/his)
– BASF Pharma Solutions
Partner Presentation Speaker:
Sandip Tiwari, PhD (he/him/his)
– BASF Corporation
Formulation and Delivery
9:30 AM – 10:30 AM
MT
Mitigating Nitrosamine Risks: An In-Silico Approach to Identifying NDSRIs and Evaluating API-Excipient Interactions
Location: 360 Stage #4, Exhibit Hall
Partner Presentation Speaker:
Rainer Dobrawa, PhD (he/him/his)
– BASF Pharma Solutions
Partner Presentation Speaker:
Sandip Tiwari, PhD (he/him/his)
– BASF Corporation
Formulation and Delivery
Sponsored By
9:30 AM – 10:30 AM
MT
Speed to Market: The Power of Controlled Release Formulated Systems
Partner Presentation Speaker:
Lawrence Martin, BS
– Colorcon
Partner Presentation Speaker:
Ali Rajabi-Siahboomi
– Colorcon
Formulation and Delivery
9:30 AM – 10:30 AM
MT
Speed to Market: The Power of Controlled Release Formulated Systems
Location: 360 Stage #2, Exhibit Hall
Partner Presentation Speaker:
Lawrence Martin, BS
– Colorcon
Partner Presentation Speaker:
Ali Rajabi-Siahboomi
– Colorcon
Formulation and Delivery
Sponsored By
10:00 AM – 10:45 AM
MT
Advancements in Oral Drug Delivery via Drug Pelleting
Chalk Talk Presenter:
Lauren G. Petraglia, BS
– LCI Corporation
Formulation and Delivery
10:00 AM – 10:45 AM
MT
Advancements in Oral Drug Delivery via Drug Pelleting
Location: Spotlight Stage C, Aisle 2800, Exhibit Hall
Chalk Talk Presenter:
Lauren G. Petraglia, BS
– LCI Corporation
Formulation and Delivery
Sponsored By
10:00 AM – 11:00 AM
MT
Hot Topic: Beyond the Hype: The Realities of AI in Drug Discovery
Hot Topic Speaker:
Eric Luellen, Msc, MPH (he/him/his)
– Turing Biosciences LLC
Hot Topic Moderator:
Md Masud Parvez, PhD (he/him/his)
– AbbVie Inc.
Discovery and Basic Research
10:00 AM – 11:00 AM
MT
Hot Topic: Beyond the Hype: The Realities of AI in Drug Discovery
Location: 250 ABC
Hot Topic Speaker:
Eric Luellen, Msc, MPH (he/him/his)
– Turing Biosciences LLC
Hot Topic Moderator:
Md Masud Parvez, PhD (he/him/his)
– AbbVie Inc.
Discovery and Basic Research
10:00 AM – 11:00 AM
MT
Speaker Spotlight: Optimizing CAR T Cell Trials: Guidance on Developing and Validating Flow Cytometry Assays for Pharmacokinetics in Clinical Trials
Spotlight Speaker:
Kevin Lang, PhD (he/him/his)
– PPD, part of Thermo Fisher Scientific
Moderator:
Long Yuan, PhD
– Biogen Inc.
Bioanalytics
10:00 AM – 11:00 AM
MT
Speaker Spotlight: Optimizing CAR T Cell Trials: Guidance on Developing and Validating Flow Cytometry Assays for Pharmacokinetics in Clinical Trials
Location: Spotlight Stage A, Aisle 1100, Exhibit Hall
Spotlight Speaker:
Kevin Lang, PhD (he/him/his)
– PPD, part of Thermo Fisher Scientific
Moderator:
Long Yuan, PhD
– Biogen Inc.
Bioanalytics
10:00 AM – 11:00 AM
MT
Speaker Spotlight: Overcoming Challenges in Manufacturing and Scale-up of CGT (Cell and Gene Therapy)
Spotlight Speaker:
Raghu Malapaka, PhD
– AGC Biologics
Moderator:
Sai Chamarthy
Manufacturing & Analytical Characterization
10:00 AM – 11:00 AM
MT
Speaker Spotlight: Overcoming Challenges in Manufacturing and Scale-up of CGT (Cell and Gene Therapy)
Location: Spotlight Stage B, Aisle 1100, Exhibit Hall
Spotlight Speaker:
Raghu Malapaka, PhD
– AGC Biologics
Moderator:
Sai Chamarthy
Manufacturing & Analytical Characterization
10:30 AM – 11:30 AM
MT
Analytical Method Advances in Measuring Nitrites in Pharmaceutical Excipients
Partner Presentation Speaker:
Koudi Zhu, MS
– IFF Pharma Solutions
Manufacturing & Analytical Characterization
10:30 AM – 11:30 AM
MT
Analytical Method Advances in Measuring Nitrites in Pharmaceutical Excipients
Location: 360 Stage #3, Exhibit Hall
Partner Presentation Speaker:
Koudi Zhu, MS
– IFF Pharma Solutions
Manufacturing & Analytical Characterization
Sponsored By
10:30 AM – 11:30 AM
MT
Evaluation of Solid Self-Emulsifying Drug Delivery System by Fluid-Bed Technology
Partner Presentation Speaker:
Tasneem Gandhi, n/a
– Glatt Group - Pharmaceutical Services CDMO Unlimited
Formulation and Delivery
10:30 AM – 11:30 AM
MT
Evaluation of Solid Self-Emulsifying Drug Delivery System by Fluid-Bed Technology
Location: 360 Stage #1, Exhibit Hall
Partner Presentation Speaker:
Tasneem Gandhi, n/a
– Glatt Group - Pharmaceutical Services CDMO Unlimited
Formulation and Delivery
Sponsored By
10:30 AM – 11:30 AM
MT
How to Negotiate Contracts Like a Pro
Career Center Speaker:
Prabu Nambiar, PhD MBA FRAPS (he/him/his)
– Syner-G Biopharma Group
Career Center Speaker:
Ashok Dang, PhD
– Perkin Elmer
Career Center Speaker:
Kim Huynh-Ba, M.S., PMP, FAAPS
– Pharmalytik
Career Development
10:30 AM – 11:30 AM
MT
How to Negotiate Contracts Like a Pro
Location: Careers 360, Exhibit Hall
Career Center Speaker:
Prabu Nambiar, PhD MBA FRAPS (he/him/his)
– Syner-G Biopharma Group
Career Center Speaker:
Ashok Dang, PhD
– Perkin Elmer
Career Center Speaker:
Kim Huynh-Ba, M.S., PMP, FAAPS
– Pharmalytik
Career Development
11:00 AM – 1:30 PM
MT
Dedicated Solution Center Hours
11:00 AM – 1:30 PM
MT
Dedicated Solution Center Hours
Location: Exhibit Halls 1 and A-D
11:30 AM – 12:25 PM
MT
Special Poster Collection
11:30 AM – 12:25 PM
MT
Special Poster Collection
Location: Poster Forum #8, Exhibit Hall
Poster Collection Host:
Annette Bak, Ph.D., M.B.A., FAAPS (she/her/hers)
– AstraZeneca
Poster Collection Moderator:
Erica Schlesinger, Ph.D. (she/her/hers)
– Serán Bioscience
11:30 AM – 12:30 PM
MT
Speaker Spotlight: Omics-Driven Drug Delivery: Pioneering Precision Medicine
Spotlight Speaker:
Robert Arnold, PhD (he/him/his)
– Auburn University
Moderator:
Sibylle Neuhoff, PhD (she/her/hers)
– Certara Predictive Technologies
Preclinical, Clinical and Translational Sciences
11:30 AM – 12:30 PM
MT
Speaker Spotlight: Omics-Driven Drug Delivery: Pioneering Precision Medicine
Location: Spotlight Stage B, Aisle 1100, Exhibit Hall
Spotlight Speaker:
Robert Arnold, PhD (he/him/his)
– Auburn University
Moderator:
Sibylle Neuhoff, PhD (she/her/hers)
– Certara Predictive Technologies
Preclinical, Clinical and Translational Sciences
11:30 AM – 12:30 PM
MT
Speaker Spotlight: Patient-Focused Drug Development: CMC Considerations
Spotlight Speaker:
Hong Cai, PhD (she/her/hers)
– U.S. Food and Drug Administration
Moderator:
Josephine Aimiuwu, PhD
– U.S. Food and Drug Administration
Formulation and Delivery
11:30 AM – 12:30 PM
MT
Speaker Spotlight: Patient-Focused Drug Development: CMC Considerations
Location: Spotlight Stage C, Aisle 2800, Exhibit Hall
Spotlight Speaker:
Hong Cai, PhD (she/her/hers)
– U.S. Food and Drug Administration
Moderator:
Josephine Aimiuwu, PhD
– U.S. Food and Drug Administration
Formulation and Delivery
11:30 AM – 12:30 PM
MT
Speaker Spotlight: Synthesis and Characterization of Dual-Payload Antibody-Drug Conjugates
Spotlight Speaker:
Shawn Owen, PhD (he/him/his)
– University of Utah
Moderator:
Abhisheak Sharma, Ph.D.
– University of Florida
Discovery and Basic Research
11:30 AM – 12:30 PM
MT
Speaker Spotlight: Synthesis and Characterization of Dual-Payload Antibody-Drug Conjugates
Location: Spotlight Stage A, Aisle 1100, Exhibit Hall
Spotlight Speaker:
Shawn Owen, PhD (he/him/his)
– University of Utah
Moderator:
Abhisheak Sharma, Ph.D.
– University of Florida
Discovery and Basic Research
12:00 PM – 1:00 PM
MT
Empowering Success:Developing Transferable Skills for Graduate Students and Postdoctoral Fellows
Career Center Speaker:
Sudip K. Das, PhD (he/him/his)
– Butler University, College of Pharmacy & Health Sciences
Career Center Speaker:
Bo Tokarski, PhD, MBA
– Charles River Laboratories Ashland LLC
Career Center Moderator:
Sudip K. Das, PhD (he/him/his)
– Butler University, College of Pharmacy & Health Sciences
Career Development
12:00 PM – 1:00 PM
MT
Empowering Success:Developing Transferable Skills for Graduate Students and Postdoctoral Fellows
Location: Careers 360, Exhibit Hall
Career Center Speaker:
Sudip K. Das, PhD (he/him/his)
– Butler University, College of Pharmacy & Health Sciences
Career Center Speaker:
Bo Tokarski, PhD, MBA
– Charles River Laboratories Ashland LLC
Career Center Moderator:
Sudip K. Das, PhD (he/him/his)
– Butler University, College of Pharmacy & Health Sciences
Career Development
12:30 PM – 1:25 PM
MT
Special Poster Collection
12:30 PM – 1:25 PM
MT
Special Poster Collection
Location: Poster Forum #8, Exhibit Hall
Poster Collection Host:
Russ S. Weiner, Ph.D., FAAPS
– Takeda
1:30 PM – 2:30 PM
MT
Keynote: Impact of Immunogenicity on Gene Therapy Development – Science, Regulatory and Patients
Keynote Speaker:
Jim McNally, PhD
– BioAgilytix
Moderator:
Maria Jadhav, PhD
– Novartis Institutes for BioMedical Research, Inc.
Bioanalytics
1:30 PM – 2:30 PM
MT
Keynote: Impact of Immunogenicity on Gene Therapy Development – Science, Regulatory and Patients
Location: 150 DEFG
Keynote Speaker:
Jim McNally, PhD
– BioAgilytix
Moderator:
Maria Jadhav, PhD
– Novartis Institutes for BioMedical Research, Inc.
Bioanalytics
1:30 PM – 2:30 PM
MT
Keynote: Challenges with New Modalities: Hitting the Stride from Day 1
Keynote Speaker:
Jennifer Chadwick, PhD
– Jennifer Chadwick
Moderator:
Anuji Abraham, PhD
– Bristol-Myers Squibb Company
Manufacturing & Analytical Characterization
1:30 PM – 2:30 PM
MT
Keynote: Challenges with New Modalities: Hitting the Stride from Day 1
Location: 155 F
Keynote Speaker:
Jennifer Chadwick, PhD
– Jennifer Chadwick
Moderator:
Anuji Abraham, PhD
– Bristol-Myers Squibb Company
Manufacturing & Analytical Characterization
1:30 PM – 2:30 PM
MT
Keynote: Effective Drug Development Requires Rationales, Not Rules – Rethinking Guidance for Industry
Keynote Speaker:
Lauren Stevenson, PhD (she/her/hers)
– Immunologix Laboratories
Moderator:
Chad J. Briscoe, PhD (he/him/his)
– Celerion
Bioanalytics
1:30 PM – 2:30 PM
MT
Keynote: Effective Drug Development Requires Rationales, Not Rules – Rethinking Guidance for Industry
Location: 151 ABCG
Keynote Speaker:
Lauren Stevenson, PhD (she/her/hers)
– Immunologix Laboratories
Moderator:
Chad J. Briscoe, PhD (he/him/his)
– Celerion
Bioanalytics
1:30 PM – 2:30 PM
MT
Keynote: Innovation Through Advanced Manufacturing: What We Can Learn From the Future
Keynote Speaker:
Xiaoming Xu, PhD (he/him/his)
– US Food and Drug Administration
Moderator:
Thilak Mudalige, PhD (he/him/his)
– US Food and Drug Administration
Manufacturing & Analytical Characterization
1:30 PM – 2:30 PM
MT
Keynote: Innovation Through Advanced Manufacturing: What We Can Learn From the Future
Location: 155 E
Keynote Speaker:
Xiaoming Xu, PhD (he/him/his)
– US Food and Drug Administration
Moderator:
Thilak Mudalige, PhD (he/him/his)
– US Food and Drug Administration
Manufacturing & Analytical Characterization
1:30 PM – 2:30 PM
MT
Keynote: Materials and Protein Engineering to Counter Inflammation and Autoimmunity
Keynote Speaker:
Jeffrey A. Hubbell, PhD (he/him/his)
– University of Chicago
Moderator:
Shijie Cao
Formulation and Delivery
1:30 PM – 2:30 PM
MT
Keynote: Materials and Protein Engineering to Counter Inflammation and Autoimmunity
Location: 155 B
Keynote Speaker:
Jeffrey A. Hubbell, PhD (he/him/his)
– University of Chicago
Moderator:
Shijie Cao
Formulation and Delivery
1:30 PM – 2:30 PM
MT
Keynote: Model Informed Vaccine Development (MIVD) – Challenges and Opportunities
Keynote Speaker:
Mindy Magee, PharmD (she/her/hers)
– Clinical Pharmacology Modeling & Simulation, Infectious Diseases and Vaccines, Precision Medicine, GlaxoSmithKline
Moderator:
Vaishali Sahasrabudhe, PhD (she/her/hers)
– Pfizer Inc.
Preclinical, Clinical and Translational Sciences
1:30 PM – 2:30 PM
MT
Keynote: Model Informed Vaccine Development (MIVD) – Challenges and Opportunities
Location: 251 ABC
Keynote Speaker:
Mindy Magee, PharmD (she/her/hers)
– Clinical Pharmacology Modeling & Simulation, Infectious Diseases and Vaccines, Precision Medicine, GlaxoSmithKline
Moderator:
Vaishali Sahasrabudhe, PhD (she/her/hers)
– Pfizer Inc.
Preclinical, Clinical and Translational Sciences
1:30 PM – 2:30 PM
MT
Keynote: Modelling Prion Neurodegeneration in Human Brain Organoids; Can We Increase the Possibility of Therapeutic Success?
Keynote Speaker:
Cathryn Haigh, PhD
– NIAID, NIH
Moderator:
Rosalinde Masereeuw, PhD (she/her/hers)
– Utrecht Institute for Pharmaceutical Sciences
Discovery and Basic Research
1:30 PM – 2:30 PM
MT
Keynote: Modelling Prion Neurodegeneration in Human Brain Organoids; Can We Increase the Possibility of Therapeutic Success?
Location: 251 F
Keynote Speaker:
Cathryn Haigh, PhD
– NIAID, NIH
Moderator:
Rosalinde Masereeuw, PhD (she/her/hers)
– Utrecht Institute for Pharmaceutical Sciences
Discovery and Basic Research
1:30 PM – 8:00 PM
MT
Exhibitor Move-Out
1:30 PM – 8:00 PM
MT
Exhibitor Move-Out
Location: Exhibit Halls 1 and A-D
3:00 PM – 3:45 PM
MT
Rapid Fires: Challenges and Lessons Learned in Commercializing (Manufacturing and Product Quality Analysis) Novel Modalities 2
Rapid Fire Moderator:
Li Tian, PhD (she/her/hers)
– US Food and Drug Administration
Manufacturing & Analytical Characterization
3:00 PM – 3:45 PM
MT
Rapid Fires: Challenges and Lessons Learned in Commercializing (Manufacturing and Product Quality Analysis) Novel Modalities 2
Location: 155 F
Rapid Fire Moderator:
Li Tian, PhD (she/her/hers)
– US Food and Drug Administration
Manufacturing & Analytical Characterization
3:00 PM – 3:15 PM
MT
Instigation of Protein Aggregate Formation by PS80 Degradation Products
Location: 155 F
Rapid Fire Speaker:
Laura A. Philips, PhD
– Spheryx, Inc.
Manufacturing & Analytical Characterization
3:15 PM – 3:30 PM
MT
Mitigating Aggregation in pH Sensitive Monoclonal Antibodies During Viral Inactivation
Location: 155 F
Rapid Fire Speaker:
Shiqi Hong, PhD (she/her/hers)
– Roquette
Manufacturing & Analytical Characterization
3:30 PM – 3:45 PM
MT
Measurement and Control of Host Cell Proteins for Biopharmaceutical Development
Location: 155 F
Rapid Fire Speaker:
Xuanwen (Shawn) Li, PhD
– Merck & Co. Inc.
Manufacturing & Analytical Characterization
3:00 PM – 4:00 PM
MT
Hot Topic: PK/PD and Translational Considerations for LNP Delivered Gene Editing Products
Hot Topic Speaker:
Bahru Habtemariam, Pharm.D.
– Beam Therapeutics
Hot Topic Moderator:
Salvatore Iovino
Preclinical, Clinical and Translational Sciences
3:00 PM – 4:00 PM
MT
Hot Topic: PK/PD and Translational Considerations for LNP Delivered Gene Editing Products
Location: 250 ABC
Hot Topic Speaker:
Bahru Habtemariam, Pharm.D.
– Beam Therapeutics
Hot Topic Moderator:
Salvatore Iovino
Preclinical, Clinical and Translational Sciences
3:00 PM – 4:00 PM
MT
Hot Topic: Trends in Utility of Animal Studies in Oral Drug Development
Hot Topic Speaker:
Bart Hens, PharmD, PhD (he/him/his)
– Pfizer
Hot Topic Speaker:
Filippos Kesisoglou, Ph.D. (he/him/his)
– Merck & Co., Inc.
Hot Topic Speaker:
Stephen D. Stamatis, PhD
– Eli Lilly and Company
Hot Topic Moderator:
Siddhi S. Hate, PhD
– Eli Lilly and Company
Hot Topic Speaker:
Nikoletta Fotaki, PhD
– University of Bath
Formulation and Delivery
3:00 PM – 4:00 PM
MT
Hot Topic: Trends in Utility of Animal Studies in Oral Drug Development
Location: 155 A
Hot Topic Speaker:
Bart Hens, PharmD, PhD (he/him/his)
– Pfizer
Hot Topic Speaker:
Filippos Kesisoglou, Ph.D. (he/him/his)
– Merck & Co., Inc.
Hot Topic Speaker:
Stephen D. Stamatis, PhD
– Eli Lilly and Company
Hot Topic Moderator:
Siddhi S. Hate, PhD
– Eli Lilly and Company
Hot Topic Speaker:
Nikoletta Fotaki, PhD
– University of Bath
Formulation and Delivery
3:00 PM – 4:00 PM
MT
Rapid Fires: Advanced Drug Delivery Technologies for Targeted Therapeutics 1
Rapid Fire Moderator:
Jing Ling, Ph.D.
– Merck & Co., Inc.
Formulation and Delivery
3:00 PM – 4:00 PM
MT
Rapid Fires: Advanced Drug Delivery Technologies for Targeted Therapeutics 1
Location: 155 B
Rapid Fire Moderator:
Jing Ling, Ph.D.
– Merck & Co., Inc.
Formulation and Delivery
3:00 PM – 3:15 PM
MT
Tuning the Organ-Selectivity of mRNA Expression through Dendrimer-Based Lipid Nanoparticles
Location: 155 B
Rapid Fire Speaker:
Zijing Xu, M.S.
– University of Florida College of Pharmacy
Formulation and Delivery
3:15 PM – 3:30 PM
MT
Antigen Capturing Nanoparticle Boosted cDC1 for in situ Cancer Immunization
Location: 155 B
Rapid Fire Speaker:
Chih-Jia Chao, Pharm.D. (she/her/hers)
– University of Illinois Chicago
Formulation and Delivery
3:30 PM – 3:45 PM
MT
Engineering Split Enzyme Systems for Tageted Drug Delivery
Location: 155 B
Rapid Fire Speaker:
Morgan C. Marsh (she/her/hers)
– University of Utah, College of Pharmacy
Formulation and Delivery
3:45 PM – 4:00 PM
MT
Non-Aqueous Emulsification Based Polymeric Microspheres for Sustained Delivery of Biologics
Location: 155 B
Rapid Fire Speaker:
Nishant Kulkarni, PhD
– Regeneron Pharmaceuticals
Formulation and Delivery
3:00 PM – 4:00 PM
MT
Rapid Fires: Advanced Drug Delivery Technologies for Targeted Therapeutics 2
Rapid Fire Moderator:
Nitesh K. Kunda, PhD
– St. John's University
Formulation and Delivery
3:00 PM – 4:00 PM
MT
Rapid Fires: Advanced Drug Delivery Technologies for Targeted Therapeutics 2
Location: 155 C
Rapid Fire Moderator:
Nitesh K. Kunda, PhD
– St. John's University
Formulation and Delivery
3:00 PM – 3:15 PM
MT
3D Printing with Tuneable Degradation: Thiol-Ene and Thiol-Yne Containing Formulations for Biomedical Applications
Location: 155 C
Rapid Fire Speaker:
Amy Locks, MS
– University College London
Formulation and Delivery
3:15 PM – 3:30 PM
MT
Intranasal Delivery of Apomorphine Freebase for Treating Parkinson's Disease
Location: 155 C
Rapid Fire Speaker:
Keedrian Olmstead, PhD
– Nano PharmaSolutions
Formulation and Delivery
3:30 PM – 3:45 PM
MT
High-Dose Engineered Powder for CNS Therapy via Inhalation
Location: 155 C
Rapid Fire Speaker:
Alan B. Watts, PhD
– Catalent
Formulation and Delivery
3:45 PM – 4:00 PM
MT
Poloxamer 188 Variant for Enhanced Formulation Stability of Biologics
Location: 155 C
Rapid Fire Speaker:
Felicitas Guth, Dr. (she/her/hers)
– BASF SE
Formulation and Delivery
3:00 PM – 4:00 PM
MT
Rapid Fires: Advancing Vaccine Development: Utilizing the Power of Model-Based Approaches 1
Rapid Fire Moderator:
Zhiyi Cui, PhD (she/her/hers)
– GSK
Preclinical, Clinical and Translational Sciences
3:00 PM – 4:00 PM
MT
Rapid Fires: Advancing Vaccine Development: Utilizing the Power of Model-Based Approaches 1
Location: 251 ABC
Rapid Fire Moderator:
Zhiyi Cui, PhD (she/her/hers)
– GSK
Preclinical, Clinical and Translational Sciences
3:00 PM – 3:15 PM
MT
Pandemic Preparedness and Role of Novel Drug Delivery Technology
Location: 251 ABC
Rapid Fire Speaker:
Jaimin R. Shah
– Genzum Life Sciences
Preclinical, Clinical and Translational Sciences
3:15 PM – 3:30 PM
MT
Propionic Acidemia/Aciduria Phase 1 Pharmacokinetics and Pharmacodynamic Distribution of LNP-mRNA-3927
Location: 251 ABC
Rapid Fire Speaker:
Christopher Rowbottom, BS
– Moderna TX
Preclinical, Clinical and Translational Sciences
3:30 PM – 3:45 PM
MT
A Rapid High Through-Put Immune Mimicking Platform for Vaccine Evaluation
Location: 251 ABC
Rapid Fire Speaker:
Dedeepya Pasupuleti, MS
– Mercer University
Preclinical, Clinical and Translational Sciences
3:45 PM – 4:00 PM
MT
Kruppel-Like Factor 2 (KLF2) Reduces Parameters of Coronavirus Disease-Related Pathogenesis
Location: 251 ABC
Rapid Fire Speaker:
Md Sariful Islam Howlader, PhD Candidate
– Texas Tech University Health Science Center
Preclinical, Clinical and Translational Sciences
3:00 PM – 4:00 PM
MT
Rapid Fires: Advancing Vaccine Development: Utilizing the Power of Model-Based Approaches 2
Rapid Fire Moderator:
Punit Marathe, PhD
– Agios Pharmaceuticals
Preclinical, Clinical and Translational Sciences
3:00 PM – 4:00 PM
MT
Rapid Fires: Advancing Vaccine Development: Utilizing the Power of Model-Based Approaches 2
Location: 251 DE
Rapid Fire Moderator:
Punit Marathe, PhD
– Agios Pharmaceuticals
Preclinical, Clinical and Translational Sciences
3:00 PM – 3:15 PM
MT
Quantitative Modeling Considerations for LNP-mRNA Therapeutics
Location: 251 DE
Rapid Fire Speaker:
Yun Liu, Ph.D
– Moderna
Preclinical, Clinical and Translational Sciences
3:15 PM – 3:30 PM
MT
Analogues of Bacterial Quorum Sensing Molecules as Potential Vaccine Adjuvants
Location: 251 DE
Rapid Fire Speaker:
Christiane Chbib, PharmD, PhD
– Larkin University
Preclinical, Clinical and Translational Sciences
3:30 PM – 3:45 PM
MT
Formulation and Analytical Considerations for Assessing CQAs of Microarray Patches
Location: 251 DE
Rapid Fire Speaker:
Sarika Namjoshi, PhD
– Vaxxas Pty Ltd
Preclinical, Clinical and Translational Sciences
3:45 PM – 4:00 PM
MT
Impact of Lyoprotectants on Product Stability of Freeze-Dried mRNA-Lipid Nanoparticles
Location: 251 DE
Rapid Fire Speaker:
Zixuan Zhen, MS (she/her/hers)
– University of Connecticut
Preclinical, Clinical and Translational Sciences
3:00 PM – 4:00 PM
MT
Rapid Fires: Challenges and Lessons Learned in Commercializing (Manufacturing and Product Quality Analysis) Novel Modalities 1
Rapid Fire Moderator:
Kevin Gurney, Ph.D. (he/him/his)
– Merck & Co., Inc.
Manufacturing & Analytical Characterization
3:00 PM – 4:00 PM
MT
Rapid Fires: Challenges and Lessons Learned in Commercializing (Manufacturing and Product Quality Analysis) Novel Modalities 1
Location: 155 E
Rapid Fire Moderator:
Kevin Gurney, Ph.D. (he/him/his)
– Merck & Co., Inc.
Manufacturing & Analytical Characterization
3:00 PM – 3:15 PM
MT
Tiny Trojans: Recent Progress on Drug Nanocrystals as Highly-Loaded Nanovectors
Location: 155 E
Rapid Fire Speaker:
Alejandro J. Paredes, Ph.D.
– Queen's University Belfast
Manufacturing & Analytical Characterization
3:15 PM – 3:30 PM
MT
Quantitative NMR (qNMR) Spectroscopy for Excipient Profiling and Deformulation: Case-Studies
Location: 155 E
Rapid Fire Speaker:
Isha Saraf, Ph.D.
– Research Center Pharmaceutical Engineering
Manufacturing & Analytical Characterization
3:30 PM – 3:45 PM
MT
Advanced Manufacturing: Personalized Therapy by Tailoring Geometry of 3D-Printed Intravaginal-Rings
Location: 155 E
Rapid Fire Speaker:
Ahmed S. Zidan, PhD (he/him/his)
– US Food and Drug Administration
Manufacturing & Analytical Characterization
3:45 PM – 4:00 PM
MT
3D-Printed Skin-Mimetic Substrates and Solid-State NMR Improves Patch Adhesion Evaluation
Location: 155 E
Rapid Fire Speaker:
Keb Mosley-Kellum, MS
– Florida A&M University College Of Pharmacy & Pharmaceutical Sciences - Tallahass
Manufacturing & Analytical Characterization
3:00 PM – 4:00 PM
MT
Rapid Fires: Innovative Methodologies for Advancing Therapeutics from Bench to Bedside
Rapid Fire Moderator:
Li Di, PhD (she/her/hers)
– Recursion
Discovery and Basic Research
3:00 PM – 4:00 PM
MT
Rapid Fires: Innovative Methodologies for Advancing Therapeutics from Bench to Bedside
Location: 251 F
Rapid Fire Moderator:
Li Di, PhD (she/her/hers)
– Recursion
Discovery and Basic Research
3:00 PM – 3:15 PM
MT
Optimization of mRNA-LNP Formulations for Targeted Drug Delivery
Location: 251 F
Rapid Fire Speaker:
Simav Gildiz (she/her/hers)
– RUTGERS, The State University of New Jersey, USA
Discovery and Basic Research
3:15 PM – 3:30 PM
MT
A Label-Free Technology to Quantify Subcellular (Un)bound Drug Concentrations
Location: 251 F
Rapid Fire Speaker:
Tom J.J Schirris (he/him/his)
– QTM BioSciences
Discovery and Basic Research
3:30 PM – 3:45 PM
MT
Modelling Chemotherapy-Induced Peripheral Neuropathy on-a-chip
Location: 251 F
Rapid Fire Speaker:
Job Komen, MD, PhD (he/him/his)
– MIMETAS B.V
Discovery and Basic Research
3:45 PM – 4:00 PM
MT
Accelerated Product Development Using Synchrotron X-ray Imaging for Microstructure Characterization
Location: 251 F
Rapid Fire Speaker:
Andrew G. Clark, PhD (he/him/his)
– digiM Solution
Discovery and Basic Research
3:00 PM – 4:00 PM
MT
Rapid Fires: Regulatory Implications for Bioanalysis 1
Rapid Fire Moderator:
Jim X. Shen, PhD (he/him/his)
– Bristol-Myers Squibb
Bioanalytics
3:00 PM – 4:00 PM
MT
Rapid Fires: Regulatory Implications for Bioanalysis 1
Location: 150 DEFG
Rapid Fire Moderator:
Jim X. Shen, PhD (he/him/his)
– Bristol-Myers Squibb
Bioanalytics
3:00 PM – 3:15 PM
MT
Bioanalytical Cross-Validation: Application of ICH M10 Guidance in Data Analysis
Location: 150 DEFG
Rapid Fire Speaker:
Mianzhi Gu, PhD (she/her/hers)
– GSK
Bioanalytics
3:15 PM – 3:30 PM
MT
Biomarker Challenges: How to Deal with Lack of Parallelism?
Location: 150 DEFG
Rapid Fire Speaker:
Marc-Olivier Pepin, BSc
– Charles River
Bioanalytics
3:30 PM – 3:45 PM
MT
Utilizing Natural Language Processing to Author Bioanalytical SOPs
Location: 150 DEFG
Rapid Fire Speaker:
Joe Rajarao, PhD, MBA (he/him/his)
– Accenture
Bioanalytics
3:45 PM – 4:00 PM
MT
LC-MS/MS Quantitation of Therapeutic Proteins in Tasso-M20 Dried Blood Samples
Location: 150 DEFG
Rapid Fire Speaker:
Margarita Semis, PhD (she/her/hers)
– Amgen Inc
Bioanalytics
3:00 PM – 4:00 PM
MT
Rapid Fires: Regulatory Implications for Bioanalysis 2
Rapid Fire Moderator:
Mahadevan (Maha) Lakshminarasimhan, PhD (he/him/his)
– Merck & Co., Inc.
Bioanalytics
3:00 PM – 4:00 PM
MT
Rapid Fires: Regulatory Implications for Bioanalysis 2
Location: 151 ABCG
Rapid Fire Moderator:
Mahadevan (Maha) Lakshminarasimhan, PhD (he/him/his)
– Merck & Co., Inc.
Bioanalytics
3:00 PM – 3:15 PM
MT
Problematic Aggregation of Biotinylated and Sulfo-Tagged Proteins in Immunoassays
Location: 151 ABCG
Rapid Fire Speaker:
Bao Lam, PhD (he/him/his)
– Resolian
Bioanalytics
3:15 PM – 3:30 PM
MT
Leveraging HRMS to Characterize Critical Reagents for Biologics Drug Development
Location: 151 ABCG
Rapid Fire Speaker:
Mahadevan (Maha) Lakshminarasimhan, PhD (he/him/his)
– Merck & Co., Inc.
Bioanalytics
3:30 PM – 3:45 PM
MT
Challenges in Critical Reagents and ADA Assays for Cell Therapy
Location: 151 ABCG
Rapid Fire Speaker:
Kun Yang, PhD
– Bristol Myers Squibb
Bioanalytics
3:45 PM – 4:00 PM
MT
Model Informed Assay Development Improves Understanding of ADA Assay Results
Location: 151 ABCG
Rapid Fire Speaker:
Gregor Jordan, M.Eng.
– Roche Diagnostics GmbH
Bioanalytics
4:15 PM – 5:30 PM
MT
Closing Plenary: AI and AI-assisted Approaches in Pharmaceutical Discovery and Development
Plenary Speaker:
Piet H. van der Graaf, Pharm.D., Ph.D.
– Certara
4:15 PM – 5:30 PM
MT
Closing Plenary: AI and AI-assisted Approaches in Pharmaceutical Discovery and Development
Location: Grand Ballroom A-J
Plenary Speaker:
Piet H. van der Graaf, Pharm.D., Ph.D.
– Certara
5:30 PM – 6:30 PM
MT
Closing Reception
5:30 PM – 6:30 PM
MT
Closing Reception
Location: Sundance Terrace, Hyatt Regency Salt Lake City
Sponsored By: